NSE filing, NSE: GJL. Summary written from the filing by ALFA Finder's alert engine.
Grover Jewells Ltd: key numbers
- Share price
- ₹337.70
- Market cap
- ₹489.9 Cr
- Revenue (annual)
- ₹824.2 Cr
- Net profit (annual)
- ₹21.17 Cr
- P/E (TTM)
- 23.1×Sector 49.5×
- Promoter holding
- 73.61%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Grover Jewells Ltd
All →Grover Jewells Partnership
Grover Jewells Limited has secured a preferred partnership and authorized dealership from MMTC-PAMP India Private Limited. The agreement permits offline retailing of minted gold and silver coins and bars.
- From
- MMTC-PAMP India Private Limited
Grover Jewells Other Announcement
Grover Jewells Limited has intimated that it is not required to submit a Quarterly Compliance Report on Corporate Governance, as it is listed on the SME platform.
Grover Jewells Annual General Meeting
Grover Jewells Limited held its 5th Annual General Meeting on September 21, 2026. The meeting covered the adoption of financial statements and re-appointment of the MD.
Grover Jewells Fund Raise of ₹30 Cr
Grover Jewells' board approved a Rs 30 Crore loan/credit facility from Bandhan Bank. The approval adds banking support to the company's working capital.
- Value
- ₹30.00 Cr
- From
- Bandhan Bank Limited
Grover Jewells Other Announcement
Grover Jewells Limited has provided the web link for its 05th Annual General Meeting notice and Annual Report for FY 2025-26. The AGM is scheduled for September 21, 2026.
Grover Jewells Debt & Borrowing: ₹23 Cr
Grover Jewells Limited approved a loan/credit facility from Axis Bank amounting to Rs. 23 Crore. This board outcome secures additional credit for the company.
- Value
- ₹23.00 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.